Anti-cxcr3 antibodies
The present disclosure provides anti-CXCR3 antibodies and methods of using the antibodies to diagnose and/or treat CXCR3-associated disorders such as diabetes mellitus type I (T1D), particularly new-onset T1D. In certain embodiments, disclosed herein are CXCR3 neutralizing antibodies.
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CONNORS TIMOTHY D PINCKNEY JASON ROBERT LODIE TRACEY TEDSTONE JENNIFER CHU RUIYIN YOUD MICHELE CARTER KAREN B MASTERJOHN ELIZABETH |
| description | The present disclosure provides anti-CXCR3 antibodies and methods of using the antibodies to diagnose and/or treat CXCR3-associated disorders such as diabetes mellitus type I (T1D), particularly new-onset T1D. In certain embodiments, disclosed herein are CXCR3 neutralizing antibodies. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN104507967A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN104507967A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN104507967A3</originalsourceid><addsrcrecordid>eNrjZBB1zCvJ1E2uSC4yVkgEMpPyUzJTi3kYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSbyzn6GBiamBuaWZuaMxMWoAWcUg6A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Anti-cxcr3 antibodies</title><source>esp@cenet</source><creator>CONNORS TIMOTHY D ; PINCKNEY JASON ROBERT ; LODIE TRACEY ; TEDSTONE JENNIFER ; CHU RUIYIN ; YOUD MICHELE ; CARTER KAREN B ; MASTERJOHN ELIZABETH</creator><creatorcontrib>CONNORS TIMOTHY D ; PINCKNEY JASON ROBERT ; LODIE TRACEY ; TEDSTONE JENNIFER ; CHU RUIYIN ; YOUD MICHELE ; CARTER KAREN B ; MASTERJOHN ELIZABETH</creatorcontrib><description>The present disclosure provides anti-CXCR3 antibodies and methods of using the antibodies to diagnose and/or treat CXCR3-associated disorders such as diabetes mellitus type I (T1D), particularly new-onset T1D. In certain embodiments, disclosed herein are CXCR3 neutralizing antibodies.</description><language>eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150408&DB=EPODOC&CC=CN&NR=104507967A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150408&DB=EPODOC&CC=CN&NR=104507967A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CONNORS TIMOTHY D</creatorcontrib><creatorcontrib>PINCKNEY JASON ROBERT</creatorcontrib><creatorcontrib>LODIE TRACEY</creatorcontrib><creatorcontrib>TEDSTONE JENNIFER</creatorcontrib><creatorcontrib>CHU RUIYIN</creatorcontrib><creatorcontrib>YOUD MICHELE</creatorcontrib><creatorcontrib>CARTER KAREN B</creatorcontrib><creatorcontrib>MASTERJOHN ELIZABETH</creatorcontrib><title>Anti-cxcr3 antibodies</title><description>The present disclosure provides anti-CXCR3 antibodies and methods of using the antibodies to diagnose and/or treat CXCR3-associated disorders such as diabetes mellitus type I (T1D), particularly new-onset T1D. In certain embodiments, disclosed herein are CXCR3 neutralizing antibodies.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBB1zCvJ1E2uSC4yVkgEMpPyUzJTi3kYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSbyzn6GBiamBuaWZuaMxMWoAWcUg6A</recordid><startdate>20150408</startdate><enddate>20150408</enddate><creator>CONNORS TIMOTHY D</creator><creator>PINCKNEY JASON ROBERT</creator><creator>LODIE TRACEY</creator><creator>TEDSTONE JENNIFER</creator><creator>CHU RUIYIN</creator><creator>YOUD MICHELE</creator><creator>CARTER KAREN B</creator><creator>MASTERJOHN ELIZABETH</creator><scope>EVB</scope></search><sort><creationdate>20150408</creationdate><title>Anti-cxcr3 antibodies</title><author>CONNORS TIMOTHY D ; PINCKNEY JASON ROBERT ; LODIE TRACEY ; TEDSTONE JENNIFER ; CHU RUIYIN ; YOUD MICHELE ; CARTER KAREN B ; MASTERJOHN ELIZABETH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN104507967A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>CONNORS TIMOTHY D</creatorcontrib><creatorcontrib>PINCKNEY JASON ROBERT</creatorcontrib><creatorcontrib>LODIE TRACEY</creatorcontrib><creatorcontrib>TEDSTONE JENNIFER</creatorcontrib><creatorcontrib>CHU RUIYIN</creatorcontrib><creatorcontrib>YOUD MICHELE</creatorcontrib><creatorcontrib>CARTER KAREN B</creatorcontrib><creatorcontrib>MASTERJOHN ELIZABETH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CONNORS TIMOTHY D</au><au>PINCKNEY JASON ROBERT</au><au>LODIE TRACEY</au><au>TEDSTONE JENNIFER</au><au>CHU RUIYIN</au><au>YOUD MICHELE</au><au>CARTER KAREN B</au><au>MASTERJOHN ELIZABETH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Anti-cxcr3 antibodies</title><date>2015-04-08</date><risdate>2015</risdate><abstract>The present disclosure provides anti-CXCR3 antibodies and methods of using the antibodies to diagnose and/or treat CXCR3-associated disorders such as diabetes mellitus type I (T1D), particularly new-onset T1D. In certain embodiments, disclosed herein are CXCR3 neutralizing antibodies.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_CN104507967A |
| source | esp@cenet |
| subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
| title | Anti-cxcr3 antibodies |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T02%3A59%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CONNORS%20TIMOTHY%20D&rft.date=2015-04-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN104507967A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |